Literature DB >> 22130801

Regulation of hepcidin expression at high altitude.

Nick P Talbot1, Samira Lakhal, Thomas G Smith, Catherine Privat, Annabel H Nickol, Maria Rivera-Ch, Fabiola León-Velarde, Keith L Dorrington, David R Mole, Peter A Robbins.   

Abstract

Enhanced erythropoietic drive and iron deficiency both influence iron homeostasis through the suppression of the iron regulatory hormone hepcidin. Hypoxia also suppresses hepcidin through a mechanism that is unknown. We measured iron indices and plasma hepcidin levels in healthy volunteers during a 7-day sojourn to high altitude (4340 m above sea level), with and without prior intravenous iron loading. Without prior iron loading, a rapid reduction in plasma hepcidin was observed that was almost complete by the second day at altitude. This occurred before any index of iron availability had changed. Prior iron loading delayed the decrease in hepcidin until after the transferrin saturation, but not the ferritin concentration, had normalized. We conclude that hepcidin suppression by the hypoxia of high altitude is not driven by a reduction in iron stores.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22130801     DOI: 10.1182/blood-2011-03-341776

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

Review 1.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

Review 2.  The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions.

Authors:  Maria Mastrogiannaki; Pavle Matak; Carole Peyssonnaux
Journal:  Blood       Date:  2013-05-15       Impact factor: 22.113

3.  Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders.

Authors:  Tsewang Tashi; N Scott Reading; Tanna Wuren; Xu Zhang; Lorna G Moore; Hao Hu; Feng Tang; Anna Shestakova; Felipe Lorenzo; Tatiana Burjanivova; Parvaiz Koul; Prasenjit Guchhait; Carl T Wittwer; Colleen G Julian; Binal Shah; Chad D Huff; Victor R Gordeuk; Josef T Prchal; RiLi Ge
Journal:  J Mol Med (Berl)       Date:  2017-02-23       Impact factor: 4.599

4.  Progesterone receptor membrane component-1 regulates hepcidin biosynthesis.

Authors:  Xiang Li; David K Rhee; Rajeev Malhotra; Claire Mayeur; Liam A Hurst; Emily Ager; Georgia Shelton; Yael Kramer; David McCulloh; David Keefe; Kenneth D Bloch; Donald B Bloch; Randall T Peterson
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

Review 5.  Serum testosterone levels and excessive erythrocytosis during the process of adaptation to high altitudes.

Authors:  Gustavo F Gonzales
Journal:  Asian J Androl       Date:  2013-03-25       Impact factor: 3.285

6.  Acute hypoxic exercise does not alter post-exercise iron metabolism in moderately trained endurance athletes.

Authors:  Andrew D Govus; Chris R Abbiss; Laura A Garvican-Lewis; Dorine W Swinkels; Coby M Laarakkers; Christopher J Gore; Peter Peeling
Journal:  Eur J Appl Physiol       Date:  2014-07-03       Impact factor: 3.078

7.  Hepcidin/Ferritin Quotient Helps to Predict Spontaneous Recovery from Iron Loss following Blood Donation.

Authors:  Ramin Lotfi; Christine Kroll; Dietmar Plonné; Bernd Jahrsdörfer; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2015-11-03       Impact factor: 3.747

Review 8.  Physiology of iron metabolism.

Authors:  Sophie Waldvogel-Abramowski; Gérard Waeber; Christoph Gassner; Andreas Buser; Beat M Frey; Bernard Favrat; Jean-Daniel Tissot
Journal:  Transfus Med Hemother       Date:  2014-05-12       Impact factor: 3.747

Review 9.  Molecular liaisons between erythropoiesis and iron metabolism.

Authors:  Leon Kautz; Elizabeta Nemeth
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

10.  Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis.

Authors:  Qingdu Liu; Olena Davidoff; Knut Niss; Volker H Haase
Journal:  J Clin Invest       Date:  2012-11-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.